Join our Drug Affordability Action Team to receive regular updates and access to strategy calls, feedback surveys, webinars, and calls to action.
This action team is committed to working toward solutions to today's out of control drug prices, which are preventing so many of our patients from accessing the treatments they need to lead healthy and productive lives. The action team's steering committee is comprised of Reshma Ramachandran, Mark Rood, Hussain Lalani, Justin Lowenthal, and Eamon Duffy. We're building out both the action team and the steering committee - join us today!
Take Action This Summer 2019 on Drug Affordability!
Across the political spectrum and all across the country, our patients are telling Congress, “Do something about the high cost of prescription drugs!” Momentum toward real action is building in Washington, D.C.
Policymakers on both sides of the aisle have proposed solutions, but the pharmaceutical industry lobby is blocking these ideas from becoming a reality.
We need to join our patients in asking for real change. As physicians, we witness the struggles our patients face trying to pay for the lifesaving drugs they need. We have an opportunity this summer to make a difference.
Featured speakers include:
Justin Mendoza is the State Partnerships Manager at Families USA. He also work on Families USA's drug pricing projects, where he provides strategic guidance and expertise on prescription drug pricing polices, and co-ordinates a monthly organizing table connecting organizations working to mobilize for lower drug prices.
Afton Cissell serves as Senior Counsel to Congressman Lloyd Doggett, Chairman of the House Ways & Means Health Subcommittee. In her current role, Afton oversees the House Affordable Prescription Drug Task Force and the health subcommittee’s work. She was previously a Staff Attorney with the National Health Law Program. Afton received her J.D. from Harvard Law School and B.S. from New York University.
Aaron Kesselheim, MD JD MPH, is Assoc. Professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Dept. of Medicine at Brigham and Women’s Hospital. Dr. Kesselheim created and leads the Program on Regulation, Therapeutics, And Law (PORTAL), a research core focusing on intersections among prescription drugs and medical devices, patient health outcomes, and regulatory practices and the law.
To get involved in our drug pricing campaign contact email@example.com.